Maxpro Capital Acquisition
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch JMAC and buy or sell other stocks, ETFs, and their options commission-free!About JMAC
Apollomics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of oncology therapies to address unmet medical needs. The company was founded by Liang Yu Guo and Sanjeev Redkar in May 2015 and is headquartered in Foster City, CA.
CEOHung Wen Chen
CEOHung Wen Chen
Employees13
Employees13
HeadquartersFoster City, California
HeadquartersFoster City, California
Founded2015
Founded2015
Employees13
Employees13
JMAC Key Statistics
Market cap707.99K
Market cap707.99K
Price-Earnings ratio-0.30
Price-Earnings ratio-0.30
Dividend yield—
Dividend yield—
Average volume41.11K
Average volume41.11K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$42.12
52 Week high$42.12
52 Week low$3.66
52 Week low$3.66
Stock Snapshot
The current Maxpro Capital Acquisition(JMAC) stock price is $0.64, with a market capitalization of 707.99K. The stock trades at a price-to-earnings (P/E) ratio of -0.30.
Maxpro Capital Acquisition(JMAC) stock opened on 2025-12-06 at —. The price climbed to — and dipped to —.
Maxpro Capital Acquisition(JMAC) shares are trading with a volume of 0, against a daily average of 41.11K.
During the past year, Maxpro Capital Acquisition(JMAC) stock moved between $3.66 at its lowest and $42.12 at its peak.
During the past year, Maxpro Capital Acquisition(JMAC) stock moved between $3.66 at its lowest and $42.12 at its peak.
People also own
Based on the portfolios of people who own JMAC. This list is generated using Robinhood data, and it’s not a recommendation.